Description
Developer of digital PCR diagnostic system designed to focus on the microfluidic technology in vitro diagnostic platforms. The PCR system can digitize the medical test results, and the results can be used for medication guidance or predictive treatment, etc, providing reliable digital support for medical practitioners and researchers.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC | 30-Aug-2021 | 00.000 | Completed | Generating Revenue | ||
3. Early Stage VC | 27-Mar-2020 | 00.000 | 00.000 | Completed | Generating Revenue | |
2. Early Stage VC | 01-Mar-2019 | Completed | Generating Revenue | |||
1. Accelerator/Incubator | 31-Dec-2017 | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3860753-A1 | Pressure insensitive microfluidic circuit for droplet generation and uses thereof | Pending | 18-Oct-2018 | 000000000000 | |
US-20210370303-A1 | Pressure insensitive microfluidic circuit for droplet generation and uses thereof | Pending | 18-Oct-2018 | 0000000000 | |
US-20210308678-A1 | Co-detection and digital quantification of bioassay | Pending | 27-Aug-2018 | C12Q1/6851 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Guohui Zhou Ph.D | Chief Executive Officer & Co-Founder |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
DT Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Juffett Investment | Venture Capital | Minority | 000 0000 | 000000 0 | |
Shenzhen Xinzheng Asset Management | Fund of Funds | Minority | 000 0000 | 000000 0 | |
HKUST Business School | University | Minority | 000 0000 | 000000 0 |